Matrine promotes liver cancer cell apoptosis by inhibiting mitophagy and PINK1/Parkin pathways

Matrine is a natural alkaloid isolated from the root and stem of the legume plant Sophora. Its anti-proliferative and pro-apoptotic effects on several types of Cancer have been well-documented. However, the role of matrine in regulating mitochondrial homeostasis, particularly Mitophagy in liver cancer Apoptosis, remains uncertain. The aim of our study was to explore whether matrine promotes liver Cancer cell Apoptosis by modifying Mitophagy. HepG2 cells were used in the study and treated with different doses of matrine. Cell viability and Apoptosis were determined by MTT assay, TUNEL staining, western blotting, and LDH release assay. Mitophagy was monitored by immunofluorescence assay and western blotting. Mitochondrial function was assessed by immunofluorescence assay, ELISA, and western blotting. The results of our study indicated that matrine treatment dose-dependently reduced cell viability and increased the apoptotic rate of HepG2 cells. Functional studies demonstrated that matrine treatment induced mitochondrial dysfunction and activated mitochondrial Apoptosis by inhibiting protective Mitophagy. Re-activation of Mitophagy abolished the pro-apoptotic effects of matrine on HepG2 cells. Molecular investigations further confirmed that matrine regulated Mitophagy via the PINK1/Parkin pathways. Matrine blocked the PINK1/Parkin pathways and repressed Mitophagy, whereas activation of the PINK1/Parkin pathways increased Mitophagy activity and promoted HepG2 cell survival in the presence of matrine. Together, our data indicated that matrine promoted HepG2 cell Apoptosis through a novel mechanism that acted via inhibiting Mitophagy and the PINK1/Parkin pathways. This finding provides new insight into the molecular mechanism of matrine for treating liver Cancer and offers a potential target to repress liver Cancer progression by modulating Mitophagy and the PINK1/Parkin pathways.